Skip to main content

Table 4 Cox regression analysis for independent predictors of timing until LTFU at the Sheka Zonal Hospital, southwest Ethiopia, from 2010 to 2013

From: When are patients lost to follow-up in pre-antiretroviral therapy care? a retrospective assessment of patients in an Ethiopian rural hospital

Variables Crude HR 95% CI P -value AHR 95.0% CI AHR P -value
CPT at enrolment       
Provided 1.0    1.0   
Not provided 3.02 2.04–4.48 0.000 1.77 1.12–2.79 0.015
CD4 category       
<350 1.0    1.0   
≥350 7.20 2.96–17.96 0.04 1.87 1.02–3.45 0.044
Disclosure of HIV status       
To family members     1.0   
To other relatives 2.43 1.47–2.66 0.008 2.0 1.03–3.90 0.044
No disclosure 4.05 2.86–5.72 0.000 3.04 2.07–4.45 0.000
WHO clinical stage       
I/II 1.55 1.02–2.36 0.038 0.99 0.65–1.53 0.99
III/IV 1.0    1.0   
Service availability       
Within <10 km 1.0    1.0   
≥10 km 1.92 1.43–2.58 0.000 1.28 0.93–1.74 0.13
Opportunistic infections       
Yes** 1.0    1.0   
No 1.93 1.44–2.59 0.000 1.24 0.89–1.72 0.198
  1. **Reference category, CPT: co-trimoxazole prophylaxis therapy, AHR: adjusted hazard ratio, CI: confidence interval.